Schedule of Estimated Fair Values and Carrying Amounts |
The estimated fair values, and related carrying amounts, of the financial instruments and other assets included in the Company’s financial statements at July 31, 2025 and April 30, 2025 are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | July 31, 2025 | | April 30, 2025 | (In thousands) | Carrying Value | | Fair Value | | Carrying Value | | Fair Value | Cash and cash equivalents | $ | 9,666 | | | $ | 9,666 | | | $ | 9,808 | | | $ | 9,808 | | Restricted cash | 111,761 | | | 111,761 | | | 114,729 | | | 114,729 | | Inventory - Repossessions | 16,432 | | | 16,432 | | | 18,845 | | | 18,845 | | Finance receivables, net | 1,183,452 | | | 932,144 | | | 1,180,673 | | | 928,130 | | Accounts payable | 33,977 | | | 33,977 | | | 34,980 | | | 34,980 | | Contingent consideration | 6,954 | | | 6,954 | | | 6,298 | | | 6,298 | | Revolving line of credit, net | 164,394 | | | 164,394 | | | 204,769 | | | 204,769 | | | | | | | | | | Non-recourse notes payable, net | 610,750 | | | 619,380 | | | 572,010 | | | 581,029 | |
|